Protection of outbred mice against a vaginal challenge by a Chlamydia trachomatis serovar E recombinant major outer membrane protein vaccine is dependent on phosphate substitution in the adjuvant

Documenti analoghi

• Phosphate substitution in an AlOOH - TLR4 adjuvant system (SPA08) modulates the immunogenicity of Serovar E MOMP from Chlamydia trachomatis
  di: Visan, Lucian, et al.
  Pubblicazione: (2016)
• Vaccination with the Recombinant Major Outer Membrane Protein Elicits Antibodies to the Constant Domains and Induces Cross-Serovar Protection against Intranasal Challenge with Chlamydia trachomatis
  di: Tifrea, Delia F., et al.
  Pubblicazione: (2013)
• A Recombinant Chlamydia trachomatis MOMP Vaccine Elicits Cross-serogroup Protection in Mice Against Vaginal Shedding and Infertility
  di: Tifrea, Delia F, et al.
  Pubblicazione: (2020)
• Immunogenicity of a vaccine formulated with the Chlamydia trachomatis serovar F, native major outer membrane protein in a nonhuman primate model
  di: Cheng, Chunmei, et al.
  Pubblicazione: (2011)
• Enhancement of the protective efficacy of a Chlamydia trachomatis recombinant vaccine by combining systemic and mucosal routes for immunization
  di: Ralli-Jain, Pooja, et al.
  Pubblicazione: (2010)